201 related articles for article (PubMed ID: 26138072)
41. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.
Liu Y; Lv L; Xiao W; Gong C; Yin J; Wang D; Sheng H
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):365. PubMed ID: 21671179
[TBL] [Abstract][Full Text] [Related]
42. Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SH‑SY5Y human neuroblastoma cells.
Zheng Q; Liu Y; Liu W; Ma F; Zhou Y; Chen M; Chang J; Wang Y; Yang G; He G
Mol Med Rep; 2014 Jul; 10(1):89-94. PubMed ID: 24789581
[TBL] [Abstract][Full Text] [Related]
43. Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells.
Tanabe K; Matsushima-Nishiwaki R; Yamaguchi S; Iida H; Dohi S; Kozawa O
J Neuroinflammation; 2010 Mar; 7():16. PubMed ID: 20205746
[TBL] [Abstract][Full Text] [Related]
44. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells.
Hahm ER; Singh SV
Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902
[TBL] [Abstract][Full Text] [Related]
45. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
Jeon YJ; Jung SN; Yun J; Lee CW; Choi J; Lee YJ; Han DC; Kwon BM
Cancer Sci; 2015 Apr; 106(4):413-20. PubMed ID: 25611086
[TBL] [Abstract][Full Text] [Related]
46. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of phospholipase D enhances Bcl-2 expression by activating STAT3 through independent activation of ERK and p38MAPK in HeLa cells.
Choi HJ; Han JS
Biochim Biophys Acta; 2012 Jun; 1823(6):1082-91. PubMed ID: 22504301
[TBL] [Abstract][Full Text] [Related]
48. Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.
Ashizawa T; Miyata H; Ishii H; Oshita C; Matsuno K; Masuda Y; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Akiyama Y
Int J Oncol; 2011 May; 38(5):1245-52. PubMed ID: 21369699
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells.
Yu LJ; Wu ML; Li H; Chen XY; Wang Q; Sun Y; Kong QY; Liu J
Neoplasia; 2008 Jul; 10(7):736-44. PubMed ID: 18592012
[TBL] [Abstract][Full Text] [Related]
50. Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells.
Tang C; Xue HL; Huang HB; Wang XG
Neurosci Lett; 2010 Feb; 470(2):126-9. PubMed ID: 20045721
[TBL] [Abstract][Full Text] [Related]
51. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
Das S; Tosaki A; Bagchi D; Maulik N; Das DK
J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
[TBL] [Abstract][Full Text] [Related]
52. LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway.
Nadiminty N; Chun JY; Hu Y; Dutt S; Lin X; Gao AC
Biochem Biophys Res Commun; 2007 Jul; 359(2):379-84. PubMed ID: 17543278
[TBL] [Abstract][Full Text] [Related]
53. Fluacrypyrim, a novel STAT3 activation inhibitor, induces cell cycle arrest and apoptosis in cancer cells harboring constitutively-active STAT3.
Yu ZY; Huang R; Xiao H; Sun WF; Shan YJ; Wang B; Zhao TT; Dong B; Zhao ZH; Liu XL; Wang SQ; Yang RF; Luo QL; Cong YW
Int J Cancer; 2010 Sep; 127(6):1259-70. PubMed ID: 20087863
[TBL] [Abstract][Full Text] [Related]
54. Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation.
Boykin C; Zhang G; Chen YH; Zhang RW; Fan XE; Yang WM; Lu Q
Br J Cancer; 2011 Mar; 104(5):781-9. PubMed ID: 21304528
[TBL] [Abstract][Full Text] [Related]
55. GRIM‑19‑mediated Stat3 activation is a determinant for resveratrol‑induced proliferation and cytotoxicity in cervical tumor‑derived cell lines.
Li YG; Xia HJ; Tao JP; Xin P; Liu MY; Li JB; Zhu W; Wei M
Mol Med Rep; 2015 Feb; 11(2):1272-7. PubMed ID: 25351437
[TBL] [Abstract][Full Text] [Related]
56. BP‑1‑102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways.
Jiang X; Tang J; Wu M; Chen S; Xu Z; Wang H; Wang H; Yu X; Li Z; Teng L
Mol Med Rep; 2019 Apr; 19(4):2698-2706. PubMed ID: 30720080
[TBL] [Abstract][Full Text] [Related]
57. Correlation of ARHI upregulation with growth suppression and STAT3 inactivation in resveratrol-treated ovarian cancer cells.
Zhong LX; Nie JH; Liu J; Lin LZ
Cancer Biomark; 2018; 21(4):787-795. PubMed ID: 29504523
[TBL] [Abstract][Full Text] [Related]
58. Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin-proteasome pathway.
Nie XH; Ou-yang J; Xing Y; Li DY; Dong XY; Liu RE; Xu RX
Drug Des Devel Ther; 2015; 9():5611-22. PubMed ID: 26508835
[TBL] [Abstract][Full Text] [Related]
59. Anti-Cancer Potential of
An EJ; Kim Y; Lee SH; Ko HM; Chung WS; Jang HJ
Molecules; 2020 May; 25(10):. PubMed ID: 32422890
[TBL] [Abstract][Full Text] [Related]
60. Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.
Qin HR; Kim HJ; Kim JY; Hurt EM; Klarmann GJ; Kawasaki BT; Duhagon Serrat MA; Farrar WL
Cancer Res; 2008 Oct; 68(19):7736-41. PubMed ID: 18829527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
